|
|
(HealthNewsDigest.com) – New research on failed Alzheimer’s compound from Eli Lilly suggests that the drug had a long-term negative effect on patients’ cognitive abilities, raising questions about other experimental drugs in the same class.
http://online.wsj.com/article/SB10001424052702304567604576456370650937208.html?mod=djemHL_t
###
Subscribe to our FREE Ezine and receive current Health News, be eligible for discounted products/services and coupons related to your Health. We publish 24/7.
www.HealthNewsDigest.com
For advertising/promotion, email: [email protected] Or call toll free: 877- 634-9180